| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| CinCor Pharma, Inc. | Director | Stock Option (Right to Buy) | 0 | Feb 24, 2023 | Direct | ||
| IPI Legacy Liquidation Co | Director | Stock Option (right to buy) | 0 | Apr 5, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| IMPLQ | IPI Legacy Liquidation Co | Apr 5, 2024 | 3 | $0 | 4 | Apr 9, 2024 | Director |
| IMPL | IMPEL PHARMACEUTICALS INC | Jun 16, 2023 | 1 | $0 | 4 | Jun 20, 2023 | Director |
| CINC | CinCor Pharma, Inc. | Feb 24, 2023 | 5 | $0 | 4 | Feb 24, 2023 | Director |
| CINC | CinCor Pharma, Inc. | Jan 6, 2023 | 1 | $12.5K | 4 | Jan 10, 2023 | Director |
| CINC | CinCor Pharma, Inc. | Oct 7, 2022 | 1 | $12.5K | 4 | Oct 12, 2022 | Director |
| CINC | CinCor Pharma, Inc. | Jul 8, 2022 | 1 | $12.5K | 4 | Jul 20, 2022 | Director |
| IMPL | IMPEL PHARMACEUTICALS INC | Jun 16, 2022 | 1 | $0 | 4 | Jun 17, 2022 | Director |
| CINC | CinCor Pharma, Inc. | Apr 8, 2022 | 1 | $12.5K | 4/A | Jul 20, 2022 | Director |
| CINC | CinCor Pharma, Inc. | Jan 6, 2022 | 0 | $0 | 3 | Jan 6, 2022 | Director |
| IMPL | IMPEL NEUROPHARMA INC | Jul 11, 2021 | 1 | $0 | 4 | Jul 13, 2021 | Director |